| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 634.941 | 93 |
| GSM780708 | Untreated after 4 days (C2_1) | 230.484 | 85 |
| GSM780709 | Untreated after 4 days (C3_1) | 352.064 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 607.931 | 93 |
| GSM780720 | Untreated after 4 days (C2_2) | 273.543 | 87 |
| GSM780721 | Untreated after 4 days (C3_2) | 396.424 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1760.09 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 277.419 | 87 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 3957.37 | 99 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1531.75 | 97 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 336.623 | 88 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 4011.68 | 99 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 251.726 | 86 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 469.296 | 91 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 503.894 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 270.263 | 86 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 476.419 | 91 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 646.728 | 93 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 176.813 | 82 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 308.401 | 88 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 485.887 | 91 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 166.764 | 82 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 387.378 | 90 |